ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Neuropathy Global Clinical Trials Review, H2, 2014 Published on July 2014
Report Summary Neuropathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Table of Contents 2 Introduction 6 Neuropathy 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 1/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Neuropathy to Central Nervous System Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Unaccomplished Trials of Neuropathy 25 Subjects Recruited Over a Period of Time 29 Clinical Trials by Sponsor Type 30 Prominent Sponsors 31 Top Companies Participating in Neuropathy Therapeutics Clinical Trials 32 Prominent Drugs 34 Clinical Trial Profiles 35 Clinical Trial Overview of Top Companies 35 Pfizer Inc. 35 Clinical Trial Overview of Pfizer Inc. 35 Sanofi 37 Clinical Trial Overview of Sanofi 37 NeurogesX, Inc. 38 Clinical Trial Overview of NeurogesX, Inc. 38 GW Pharmaceuticals plc 39 Clinical Trial Overview of GW Pharmaceuticals plc 39 Sumitomo Chemical Company, Limited 40 Clinical Trial Overview of Sumitomo Chemical Company, Limited 40 CSL Limited 41 Clinical Trial Overview of CSL Limited 41 Grunenthal GmbH 42 Clinical Trial Overview of Grunenthal GmbH 42 Eli Lilly and Company 43 Clinical Trial Overview of Eli Lilly and Company 43 Baxter International Inc. 44 Clinical Trial Overview of Baxter International Inc. 44 Astellas Pharma Inc. 45 Clinical Trial Overview of Astellas Pharma Inc. 45 Clinical Trial Overview of Top Institutes / Government 46 University of Texas M. D. Anderson Cancer Center 46 Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 46 National Taiwan University Hospital 47 Clinical Trial Overview of National Taiwan University Hospital 47
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 2/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! U.S. Department of Veterans Affairs 48 Clinical Trial Overview of U.S. Department of Veterans Affairs 48 Odense University Hospital 49 Clinical Trial Overview of Odense University Hospital 49 Columbia University 50 Clinical Trial Overview of Columbia University 50 The National Institute of Allergy and Infectious Diseases 51 Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51 Washington University School of Medicine 52 Clinical Trial Overview of Washington University School of Medicine 52 National Center for Research Resources 53 Clinical Trial Overview of National Center for Research Resources 53 Rigshospitalet 54 Clinical Trial Overview of Rigshospitalet 54 Oregon Health & Science University 55 Clinical Trial Overview of Oregon Health & Science University 55 Five Key Clinical Profiles 56 Appendix 129 Abbreviations 129 Definitions 129 Research Methodology 130 Secondary Research 130 About GlobalData 131 Contact Us 131 Disclaimer 131 Source 131 List of Tables
Neuropathy Therapeutics, Global, Clinical Trials by Region, 2014* 7 Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10 Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13 Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14 Proportion of Neuropathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Neuropathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2014* 21 Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22 Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 3/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Neuropathy Therapeutics, Global, Suspended Clinical Trials, 2014* 25 Neuropathy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26 Neuropathy Therapeutics, Global, Terminated Clinical Trials, 2014* 27 Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29 Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30 Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31 Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33 Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014* 38 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 39 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sumitomo Chemical Company, Limited, 2014* 40 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014* 41 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014* 42 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 43 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 44 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 45 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014* 46 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 47 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 48 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 49 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 50 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 51 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 52 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 53 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 54 Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2014* 55 List of Figures
Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10 Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13 Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14 Proportion of Neuropathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Neuropathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 4/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21 Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22 Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24 Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29 Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30 Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31 Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32 Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34 GlobalData Methodology 130
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 5/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Neuropathy Global Clinical Trials Review, H2, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 6/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Neuropathy Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 7/7